Cytokine Based Drug Development Webinar
Despite some high-profile setbacks and dropped assets, the cytokine drug-development landscape continues to flourish. In our exclusive webinar, our expert panel delved into the landscape, showcased the shift in targets, and assessed the effect of the continued challenges being faced by drug developers, to provide an extensive analysis of the dynamic landscape. Key aspects explored included:
A comprehensive overview of the evolving landscape, including cytokines as monotherapies and in combinations
Insights into the emerging trends of interleukin targets, including IL-2, IL-7, and IL-12
A picture of what we can likely expect ahead based on drugs that have been translated into the clinic so far this year.
Our Experts
Aysha Saeed
House Speaker
Lead Research Analyst
Beacon
Priya Soneji
Moderator
Account Manager
Beacon
You May Also Be Interested In…
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
